Animal model and in vitro cultures suggest that osteoclasts and cells of the mononudear phagocyte system share a common precursor. However, the human osteoclast precursor has not been positively identified. We attempted to identify the precursor in situ by using a number of osteodast-and macrophage-selective markers, together with the expression of osteopontin mRNA, previously shown to be abundant in human osteoclasts. Sections of osteophytic bone and a panel of inflammatory connective tissues were processed for in situ hybridization; serial sections were analyzed for tartrateresistant acid phosphatase (TRAP) and nonspecific esterase (NSE) activity, selective cytochemical markers for the osteoclast and cells of the macrophagelmonocyte lineage, respectively. The murine anti-human osteoclast monodonal antibodies 23C6 (vitronectin receptor) and C35 (osteodastselective) were used to further identify the osteoclast phenotype. We compared osteoclasts, giant cells, and their respective putative mononuclear precursors. At resorption sites within osteophytic bone, osteopontin mRNA was expressed in osteoclasts and a distinct population of TRAP', NSEmononudear cells. Adjacent clusters of mononudear cells were TRAP-and NSE+ or were active for both enzymes; these cells demonstrated variable expression of osteopontin "A.
Introduction
Osteoclasts, the multinucleated giant cells responsible for bone resorption, are formed by the fusion of mononuclear cells of hemopoietic origin (reviewed by Mundy and Roodman, 1987) . Although the precise nature of this precursor cell remains unknown, a large number of in vivo and in vitro studies have provided evidence that osteoclasts are derived from cells of the mononuclear phagocyte lineage (Takahashi et al., 1994; Baron et al., 1986; Marks, 1983; Gothlin and Ericsson, 1976) . Most studies of this kind have ' Correspondence to: J. R. Connor, SmithKline Beecham Pharmaceuticals, Dept. of Cellular Biochemistry, PO Box 1539, King of Prussia. PA 19406. In the idammatory connective tissues, abundant macrophage-like cells (NSE+/TRAP-) did not express osteopontin "A.
However, TRAP+ mononudear cells observed among dusters of NSE+ cells did e x p m osteopontin mRNA. At these sites, dusters of putative macrophage polykaryons removing fragments of bone debris were observed. These giant cells and associated mononudear cells were NSE-and distinctly TRAP+, and expressed osteopontin mRNA, C35, and 23C6 (human osteoclast) reactivity. Therefore, cells involved in the remodeling (resorption) of bone or the removal of bone debris, together with their immediate precursors, switch from being NSE'ITRAP-to NSE-/TRAP+ cells that express osteopontin mRNA. We propose that the clusters of NSE' I TRAPmononuclear cells represent the immature osteodast precursor. In support of this, TRAP+/NSE+ cells were occasionally observed in both tissues, representing an intermediate stage in differentiation. These results further suggest that cells of the mononuclear phagocyte lineage within bone and inflammatory connective tissue have the potential to differentiate into osteoclasts. relied on the chronological expression of macrophage-and osteoclast-associated phenotypes (Takahashi et al., 1994; Povolny and Lee, 1993; Hattersley and Chambers, 1989) . Classically, the cytochemical expression of lysosomal tartrate-resistant acid phosphatase (TRAP) and a-naphthyl acetate esterase (nonspecific esterase; NSE) activity have been used to identify osteoclasts and mononuclear phagocytes, respectively (Anderson et al., 1991; Burger and Nijweide, 1991; Baron et al., 1986) . However, despite the multitude of human osteoclast and macrophage selective markers (e.g., monoclonal antibodies), positive identification and isolation of the human osteoclast precursor have not yet been possible. The aim of this study was to make a detailed in situ analysis of individual osteoclast resorption sites in serial 5-pm sections of osteophytic bone in an attempt to identify the differential stages of osteoclast formation. Comparison was made with the population of giant cells removing fragments of disrupted bone within the associated osteoarthritic (OA) reparative/infla"atory connective tissues. These polykaryons are reported to be derived from the fusion of tissue macrophages initially stemming from populations of NSE-positive blood-borne monocytes (Holtrop et al. 1982; Owen, 1978; Adams, 1976) . Because osteoclasts share many structural, cytochemical, and functional features with macrophage polykaryons (Marks, 1983; Chambers, 1980; Gothlin and Ericsson, 1976) , it is believed that the osteoclast and macrophage polykaryon may share a common precursor. Therefore, sections of osteophyte and various types of associated connective tissues were co-localized for TRAP and NSE activity. The murine anti-human osteoclast monoclonal antibodies 23C6 (vitronectin receptor; Horton et al., 1985) , and C35 (osteoclast-selective; James et al., 1991) were used to further identify the osteoclast phenotype.
A number of recent publications have reported that osteoclasts express high levels of osteopontin mRNA, the highly abundant phosphorylated bone matrix glycoprotein (Dodds et al., in press; Takano-Yamamoto et al., 1994; Arai et al., 1993; Merry et al., 1993; Tezuka et al., 1992) . Immunolocalization studies have further revealed high concentrations of osteopontin protein in osteoclasts and their underlying resorption surfaces (Dodds et al., in press ). Therefore, the expression of osteoponin mRNA may represent a key stage in osteoclast differentiation. In support of this, Merry et al. (1993) identified a population of mononuclear cells at sites of bone resorption that expressed high levels of osteopontin mRNA. Therefore, we also assessed the expression of osteopontin mRNA in serial sections by in situ hybridization.
We present evidence that osteopontin mRNA is expressed in TRAP-positive mononuclear cells that have differentiated from a population of NSE-positive mononuclear cells in both human bone and inflammatory connective tissue, which is in keeping with the evidence that cells of the mononuclear phagocyte system have the potential to differentiate into osteoclasts. The synovial giant cell polykaryons also expressed classical osteoclast phenotypic markers in a bone environment, suggesting that these cells may in fact be true osteoclasts.
Materials and Methods
Tissue Processing. Osteophytes and associated inflammatory connective tissue (n = 6) were dissected from femoral heads removed from patients undergoing arthroplasty for osteoarthritis. The tissue was dipped briefly into a 5 % solution (wiv) of polyvinyl alcohol (PVA) and then chilled (-70°C) by precipitate immersion in cooled N-hexane (low in aromatic hydrocarbons grade; boiling range 67-70°C). Cryostat sections ( 5 pm) of unfixed, undecalcified bone were cut on a modified Hacker cryostat equipped with a finely polished tungsten-tipped steel knife. The temperature of the cryostat cabinet was kept below -25°C. The sections were picked off onto glass slides which, for in situ hybridization studies, had been coated with 3-aminopropyltriethoxy silane.
Histological Staining. Serial sections were stained with a modified aqueous Romanowsky Wright (Fast Green in methanol, eosin G. and methylene blueiazure A) (Baxter Scientific; Edison. NJ). Sections were fixed for 30 SKC in Fast Green/methanol and dipped directly into the eosin for 30 sec. Sections were stained directly with methylene blue/azure A for 1 min and washed in distilled water, air-dried, and mounted in DPX mountant (BDH Laboratory Supplies; Poole, UK).
Tartrate-resistant acid phosphatase. Unfixed, undecalcified serial cryostat sections were assayed for TRAP activity by the standard naphthol AS-BI phosphate post-coupling method, using Red Garnet GBC as the coupler (Chayen and Bitensky, 1991) . The activity was assayed at 37°C in 0.25 mM citrate buffer, pH 4.5, containing 1 mM naphthol AS-BI phosphate and 10 mM sodium tartrate; the reaction was stopped in cold distilled water and post-coupled in 0.1 mM acetate buffer, pH 6.2. containing 2.2 mM Fast Garnet GBC at 4°C for 5 min and then washed in several changes of distilled water. In the populations of cells studied in this report, tartrate had no inhibitory effect on acid phosphatase at concentrations of greater than 1 mM (range 0.1-100 mM tested; true TRAP activity). a-Naphthyl Acetate Esterase Activity. For assessing NSE activity (fluoride-inhibited). the sections were fixed for 30 sec in citrate-acetone-37% formaldehyde (CAF) and rinsed in running deionized water for 1 min. NSE activity was assessed by the standard a-naphthyl acetate esterase simultaneous coupling method (Chayen and Bitensky. 1991) (Sigma Procedure No. 91;  Sigma, St Louis, MO), using Fast Blue BB as the coupler. The activity was assayed at 37°C for 30 min. NSE activity (black/brown granulation) is detected primarily in monocytes, macrophages. and histocytes, and is virtually absent in granulocytes (light brown background staining). I t is also present in other myeloid cells, including neutrophil promyelocytes and myelocytes, megakaryocytes. and immature red cell precursors. All cells of monocytic lineage are inhibited by sodium fluoride. For dual localization of NSE and TRAP, sections were fixed and reacted for NSE, rinsed, and assayed for TRAP as described. For each tissue block studied, serial sections were reacted for NSE plus sodium fluoride (50 mM), NSE. TRAP, and NSE/TRAP. In all cases where cells were determined to be NSE' the activity was inhibited by fluoride.
Immunohistochemistry. Acetone-fixed tissue sections were overlaid with antibody diluted in 0.05 M Tris-buffered saline (TBS, pH 7.6) and a strep-[avidin-alkaline phosphatase-based (SAAP) immunoenzymatic technique was performed according to the manufacturer's protocol (GAB2 kit; Dako, Carpinteria, CA). The final reaction product was a red precipitate. Bromotetramisole 4 mM was added to the substrate to block endogenous alkaline phosphatase activity. The reaction was stopped by immersing the slides in distilled water and the sections were lightly counterstained in Mayer's hematoxylin for 30 SKC. Excess stain was removed with tapwater and the slides were mounted in 90% glycerol/lO% PBS (viv). The vitronectin receptor MAb 23C6. was obtained from Dr. M. Horton (1988) . Thegeneration and characterization of the osteoclast-selective activity C35 were described previously by James et al. (1901) .
RNA Probe. pBluescript SK containing the coding region of human osreopontin was obtained from Dr. Marian Young (NIH: Bethesda. MD). cDNA template was linearized with XhoI. then transcribed from the T3 promoter to generate the sense strand (negative control) or with Xbal. then rranscribed from the T i promoter to generate the anti-sense (positive) strand. Riboprobes were prepared using the Promega (Madison. WI) I n Vitro transcription kit with ["SI-thio CTP (Amersham. Arlington Heights, IL). After transcription, cDNA templates were digesred with RQ1 RNAse-free DNAse I (Promega) and unincorporated nucleotides were removed by centrifugation through Quik Spin Sephadex G-50 column, (Boehringer-Mannheim: Indianapolis. IN). RNA transcripts wirh a specific activity in excess of 10' cpmimg were ustd for hybridization.
In Situ Hybridization. In situ hybridization was performed by the method of Zeller and Rogers (1991) . as follows. Cryosettions were fixed in 4% paraformaldehyde for 5 min. washed, dehydrated. and frozen at ~ 20°C. Before hybridization, sections were hydrated in PBS containing 2 mgiml glycine and rinsed in PBS. Demineralization was in 0.2 N HCI for 20 min followed by acetylation in 0.25% acetic anhydride. 0.1 M triethanolamine. Finally, sections were washed twice in 2 x SSC (20 x SSC-3-M NaCI. 0.3 M Na citrate, pH 7.0), dehydrated in 30, 60, 80, 0 5 , and 100"/0 ethanol. and air-dried. Sections were used immediately for hybridizarion in buffer consisting of 2 parts hybridization mix B (1.2 M NaCI, 2 0 mM Tris-HCI, pH 7.5,4 mM EDTA, 2 x Denhardt's solution, 1 mg/ml yeast tRNA, 200 pg/ml poly A (Pharmacia; Pixataway, NJ), 2 parts deionized formamide, and 1 part 50% dextran sulfate. Dithiothreitol was added to a final concentration of 50 mM and probe concentration was 2 x 1 0 ' cpmlpl. Hybridization was carried out at 42'C for 4 hr in a well-sealed moist chamber. Post-hybridization washes were as follows: at least twice in pre-warmed 2 x SSC, 50% formamide, 0.1% 0-mercaptoethanol for 15 min at 50°C; once in 20 pglml boiled ribonuclease A in 0.5 M NaCI, 10 m M Xis-HCI, pH 8.0, for 30 min at 37°C; at least twice in pre-warmed 2 x SSC, 50% formamide, 0.1% 0-mercaptoethanol for 15 min at 5O'C; twice in pre-warmed 0.1 x SSC, 10/0 0-mercaptoethanol for 15 min at 50°C. Sections were dehydrated in the following: 0.6 M NaCI, 30% ethanol; 0.6 M NaCI, 60% ethanol; 80, 95, and 100% ethanol for 2 min each. Air-dried slides were coated with Amersham LM-1 emulsion and exposed at 4°C for 2 weeks. The slides were developed in Kodak developer and counterstained with methylene blue. The extent of the hybridization signal was assessed by the autoradiographic grain density over the cell.
Results

Histology of Osteophyte and Connective Tissues
A detailed description of the developing osteophyte (Figures 1-3 ) has been presented previously (Dodds and Gowen, 1994; Dodds et al., in press) . Three types of associated connective tissue were analyzed, each showing a particular histological feature: (a) General reparative vascular connective tissue ( Figure 4 ) consisted of discrete numbers of NSE' cells (rare) associated with large embedded fragments of bone. TRAP* cells were observed only in cells apposed to or adjacent to the bone debris. (b) Inflammatory osteoarthritic synovial/periosteal tissue ( Figure 5 ) consisted of abundant NSE' mononuclear cells located in vast clusters within or just beneath the intimal layers; others were located within the periphery of the connective tissuelosteophyte interface. Many (again at the sites of bone debris removal) TRAP' mononuclear cells and giant cells were observed forming within such clusters. (c). Granulation tissue (Figure 6 ) continuous with the periosteal connective tissue described in (b) contained abundant sites of (TRAP') giant cell formation. However, this tissue lacked the large clusters of NSE+ cells described in (b).
CO-localization of NSE and TRAP Activity: Validation
For the co-localization studies, fixation in CAF had no effect on TRAP activity. At sites in which cells had high NSE activity (dark black precipitate), analysis of serial sections reacted for the enzymes individually demonstrated that the black precipitate had not obscured any TRAP activity (Figures la and 1b) . NSE' cells were generally TRAP-and vice versa; cells demonstrating both enzyme activities (weak) were easily identified (Figures la-d ) in all tissues analyzed and potentially indicate cells at an intermediate stage of differentiation.
Osteoclasts and Mononuclear Cells at Resorption Sites in the Osteophyte
In bone sections co-reacted for TRAP and NSE activity, clusters of NSE'ITRAP-mononuclear cells were observed adjacent to osteoclasts resorbing bone (Figure 2 ). Cells demonstrating both en-zyme activities were also noted; multinucleated osteoclasts did not demonstrate NSE activity. In serial sections, strong osteopontin mRNA was observed in the TRAP+ osteoclasts and the occasional mononuclear cell close to the bone surface (Figure 2c ). NSE+ cells demonstrated no or weak osteopontin mRNA expression. Analysis of serial sections indicated that clusters of cells positive for both enzymes also demonstrated (weaker) osteopontin mRNA expression.
At resorption sites containing solely mononuclear cells (TRAP+), no NSE+ mononuclear cells were observed. This population of cells demonstrated intense osteopontin mRNA expression ( Figures  3a-3c ). Analysis of serial sections confirmed that no multinucleated osteoclasts were observed at these sites.
TUAP/NSF C e h Within Vascular
Connective Tirsue
Within the highly vascularized connective (reparative) tissue, large fragments of bone were engulfed by both TRAP+ and weakly positive TRAP/NSE cells (Figures 4a and 4b) . Osteopontin mRNA was observed in the TRAP+ cells and to a lesser extent in the TRAP+/NSE+ cells (Figure 4c ). In close proximity to the bone fragments, mononuclear cells were TRAP-and only very weakly NSE+. At these sites, clusters of osteopontin mRNA-positive mononuclear cells were observed (Figure 4c) .
Mononuclear Cells Within Inflammatory
Osteoarthritic Synovial Tissue Abundant NSE+ mononuclear cells were observed throughout the inflammatory synovial tissue ( Figures Sa and 5b) . TRAP+ cells were observed differentiating among clusters of NSE+ cells (Figure 5b) . In serial sections, osteopontin mRNA appeared to co-localize with the (occasional) TRAP" mononuclear cells (Figure 5c ).
Giant Cell Formation and Bone Debris in Osteoarthritic Granulation Tissue ana' Synovium
At sites of embedded bone debris within osteophytic granulation tissue (and inflammmatory synovium; not shown), abundant giant cell formation was observed (Figure 6a ). The giant cells and associated mononuclear cells demonstrated strong TRAP activity (Figure 6b ). Dispersed among these clusters, very weak NSE' cells were also observed. Notably, strong osteopontin mRNA was observed in both TRAP+ giant cells and adjacent mononuclear cells (Figure 6c ).
Expression of Osteoclast-selective Marhers
In the inflammatory connective tissues described above, TRAP" giant cells and associated mononuclear cells demonstrated immunoreactivity with both osteoclast-selective antibodies, 23C6 and C35 (Figures 7a and 7b, respectively) . True osteoclasts and associated mononuclear cells at resorption sites expressed 23C6 (Figure 7c ) and C35 (not shown).
Prior to bone removal, NSE+ mononuclear cells in both bone and inflammatory osteoarthritic connective tissues switch to cells expressing TRAP activity, osteopontin mRNA, and a number of i markers selective for the osteoclast phenotype. The data are summarized in Table 1 .
Discussion
In this study we used the developing human osteophyte (Dodds and Gowen, 1994) to analyze osteoclast differentiation in situ, using phenotypic markers for the osteoclast and macrophage lineages. The analysis focused on the cell types located at bone resorption sites and in the inflammatory cells located in the surrounding connective tissues. The ability to section bone at 5 pm and the use of double staining procedures enabled precise identification of cell populations in serial sections. We report for the first time in human bone the positive identification of NSE+/TRAP-mononuclear cells within defined Howship's lacunae. Furthermore, TRAP+ mononuclear cells potentially differentiated from these NSE' mononuclear cells, and in all cases fully formed multinucleated osteoclasts lacked NSE activity. One interesting observation was the demonstration of mononuclear osteoclast resorption in the osteophyte. Like their multinucleated counterparts, these cells were NSEand TRAP+. Similar observations in a rat model system (Baron et al., 1986 ) demonstrated that, before the formation of multinucleated osteoclasts, mononuclear cells positive for NSE accumulated at bone surfaces; double staining techniques revealed the activity of both TRAP and NSE enzyme activity in a proportion of these cells, indicative of a definitive stage in the differentiation of the osteoclast. Using an equivalent double staining technique, we also demonstrated cells active for both enzymes within resorption lacunae; this population was usually located between the NSE'/TRAP-cells and the TRAP' osteoclasts at the bone surface, indicative of a gradient of differentiation. Similarly, mononuclear cells (of unknown phenotype) were observed in resorption lacunae that were negative for both enzymes. Takahashi et al. (1994) , in a murine co-cultured system, also reported the disappearance of macrophage phenotypic markers, such as NSE, with the simultaneous appearance of osteoclast markers such as TRAP and the cal-citonin receptor. We have further shown that at sites of osteoclast activity the switch from NSE to TRAP activity coincided with the appearance of osteopontin mRNA expression. Thus osteopontin appears to be a relatively early marker of osteoclast differentiation.
Giant cells are a well-documented feature of diseased synovial tissue (Wilkinson et al., 1993; Grimley and Sokoloff, 1966; Collins, 1949) and inflammatory lesions in general (Popoff and Marks, 1986; Chambers, 1976; Sutton and Weiss, 1966) . Macrophagederived giant cells are commonly described (Chambers 1976) and are generally considered to be distinct from osteoclasts (Chambers, 1989; Vaes, 1988; Popoff and Marks, 1986) despite sharing a number of common antigenic features (Athanasou et al., 1992; Marks and Popoff, 1988; Horton et al., 1984) . In fact, the conclusion that the osteoclast is a member of the mononuclear phagocyte system remains controversial, because transplantation (Loutit and Nesbit, 1982) and functional experiments (Chambers and Magnus, 1982) suggest that osteoclasts and macrophages have distinct stem cells in the bone marrow and therefore separate development pathways. Further evidence to support the contention for separate differentiation pathways stems from cytochemical (Dodds et al., 1994a; Dodds and Gowen, 1992) , morphological (lack of a ruffled border; Popoff and Marks, l986), functional (scavenging and phagocytosis vs resorption of a defined amount of matrix involving no or relatively low levels of phagocytosis; Baron, 1989) , and phenotypic differences (Chambers, 1985 (Chambers, ,1989 Horton et al., 1984 Horton et al., ,1985 Hogg et al., 1980; Shapiro et al., 1979) between osteoclasts, mononuclear phagocytes, and inflammatory giant cells. It has been reported that the inflammatory giant cells resulting from the subcutaneous implantation of devitalized mineralized bone powder into rats, demonstrate functional, cytochemical, and ultrastructural features that are apparently identical to osteoclasts (Webber et al., 1990; Bagi and Miller, 1989; Glowacki and Cox, 1986; , although this has been disputed (Popoff and Marks, 1986; Holtrop et al., 1982) . These latter authors demonstrated that, unlike osteoclasts, giant cells lacked a ruffled border, and the breakdown of bone particles appeared to be primarily by phagocytosis with subsequent intracellular digestion. In our study, osteopontin mRNA expression was also noted in the TRAP+ giant cells and select TRAP+ mononuclear cells in sections of reparative connective tissue and granulation tissue/inflammatory synovium. The appearance of the giant cells and mononuclear cells was often in close association with clusters of NSE+ mononuclear cells. In an identical fashion to that described at osteoclast resorption sites, there appeared to be a switch from NSE to TRAP activity at sites of bone removal and giant cell formation that appeared to coincide with the expression of osteopontin mRNA. Furthermore, in some instances osteopontin mRNA was observed in zones of TRAP-INSE' cells that were in close proximity to bone fragments, although it is difficult to unequivocally identify them as the exact cell types in serial 5-pm sections. Nevertheless this result lends support to the early expression of osteopontin mRNA we described for osteoclast differentiation. The connective tissue giant cells and associated mononuclear cells also expressed three murine anti-human osteoclast MAbs against the vitronectin receptor: 23C6 (Horton, 1988) ; C22 (not shown; described by James et al., 1991) ; and 87MEM1 (not shown; described by James et al., 1994) and the osteoclast selective antibody, C35 Uames et al., 1991) . In this respect, the putative synovial "macrophage" giant cell was virtually indistinguishable from the osteoclast, as previously described (Wilkinson et al., 1993 ). An association between osteoclasts and monocyte/macrophages has been previously suggested on the grounds of shared antigenic determinants. MAbs raised against osteoclasts also react with cells of the monocyte/macrophage lineage (Nijweide et al., 1985; Oursler et al., 1985) . Con-versely, some antibodies raised against cells of the monocyte/macrophage lineage also demonstrate crossreactivity with osteoclasts (Athanasou et al., 1986) . However, these data could be interpreted to mean that cells merely possess a number of shared structures or functions rather than shared ontogenic pathways. Our data suggest, however, that giant cells that are formed by the fusion of tissue macrophages specific for calcified tissues (as in the inflammatory connective/bone debris tissues outlined in this study) may be pushed towards a more osteoclastic phenotype and thus demonstrate distinct antigenic differences from blood-borne monocytes and the macrophages of other tissues. Alternatively, the NSE' mononuclear cells located within the diseased (osteoarthritic) inflammatory connective tissues (derived from cells from the periosteal-chondrosynovial junction) may represent undifferentiated myeloid monocytic cells that ultimately differentiate into osteoclasts at sites of both bone debris and osteophytic bone formation. From this study it can be concluded that, before bone removal (including chemotaxis, migration, and ultimately resorption or phagocytosis), NSE' mononuclear cells in both bone and inflammatory osteoarthritic connective tissues switch to cells expressing TRAP activity, osteopontin mRNA, and a number of markers selective for the osteoclast phenotype. Although the significance of this switch remains unknown, it appears to be dependent on function associated wtih the removal of bone matrix; although not conclusive, evidence suggests that TRAP (purple acid phosphatase) is a secreted lysosomal enzyme believed to play a pivotol role in the degradation of bone extracellular matrix (reviewed by Andersson et al., 1991) . In bone, and potentially in other inflammatory connective tissues, this functional switch is further evidence to support the concept that cells of the mononuclear phagocyte system have the potential to differentiate into osteoclasts.
We previously presented data that clearly identified the osteoclast as the cell responsible for depositing osteopontin onto bone surfaces during resorption and suggested that this may promote coupling between resorption and the subsequent bone deposition.
Because osteopontin protein expression has previously been demonstrated in the bone fragments embedded in the inflammatory connective tissues (Dodds et al., 1994a) , one could speculate that this osteopontin was deposited by giant cells and may play a role in cell attachment or detachment associated with phagocytosis. In support of this, it was recently demonstrated that osteopontin dephosphorylated by TRAP in vitro no longer supported RGD-dependent osteoclast binding in vitro (Ek-Rylander et al., 1994) . Alternatively, it has been postulated that during the osteoarthritis process bone debris embedded in the synovial membrane may act as a local irritant, initiating the proliferative changes leading to osteophyte formation (Resnick and Niwayama, 1988; Jaffe, 1975) . What role os-
